We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$14.2B
1-Year Est. Return
24.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.16B
AUM Growth
–
Cap. Flow
+$8.32B
Cap. Flow
% of AUM
101.89%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
569
New
569
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$694M |
| 2 |
ExxonMobil
XOM
|
+$113M |
| 3 |
ConocoPhillips
COP
|
+$105M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$103M |
| 5 |
Becton Dickinson
BDX
|
+$101M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.73% |
| 2 | Financials | 16.49% |
| 3 | Industrials | 13.44% |
| 4 | Healthcare | 12.86% |
| 5 | Energy | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSA
526
DELISTED
National Storage Affiliates Trust
NSA
| $212K | ﹤0.01% |
+5,602
| New | +$240K |
|
527
Century Communities
CCS
$1.99B
| $211K | ﹤0.01% |
+2,876
| New | +$256K |
|
528
Orion
OEC
$387M
| $211K | ﹤0.01% |
+13,345
| New | +$225K |
|
529
Delek US
DK
$3.97B
| $209K | ﹤0.01% |
+11,282
| New | +$202K |
|
530
Procept Biorobotics
PRCT
$999M
| $207K | ﹤0.01% |
+2,575
| New | +$220K |
|
531
KB Home
KBH
$3.41B
| $206K | ﹤0.01% |
+3,129
| New | +$243K |
|
532
CarGurus
CARG
$2.97B
| $204K | ﹤0.01% |
+5,572
| New | +$191K |
|
533
Jones Lang LaSalle
JLL
$14.8B
| $201K | ﹤0.01% |
+794
| New | +$212K |
|
534
Stoke Therapeutics
STOK
$1.85B
| $199K | ﹤0.01% |
+18,049
| New | +$222K |
|
535
A10 Networks
ATEN
$2.5B
| $197K | ﹤0.01% |
+10,699
| New | +$175K |
|
536
Humacyte
HUMA
$172M
| $196K | ﹤0.01% |
+38,899
| New | +$192K |
|
537
NextDecade
NEXT
$2.11B
| $185K | ﹤0.01% |
+23,990
| New | +$154K |
|
538
Utz Brands
UTZ
$1.25B
| $183K | ﹤0.01% |
+11,690
| New | +$198K |
|
539
Marqeta
MQ
$1.76B
| $182K | ﹤0.01% |
+12,032
| New | +$211K |
|
540
Core Laboratories
CLB
$544M
| $181K | ﹤0.01% |
+10,445
| New | +$202K |
|
541
Astronics
ATRO
$3.5B
| $172K | ﹤0.01% |
+12,912
| New | +$190K |
|
|
GES
542
DELISTED
Guess Inc
GES
| $171K | ﹤0.01% |
+12,159
| New | +$207K |
|
|
OSG
543
Octave Specialty Group
OSG
$249M
| $171K | ﹤0.01% |
+13,494
| New | +$163K |
|
544
Compass
COMP
$8.05B
| $168K | ﹤0.01% |
+28,754
| New | +$182K |
|
545
Community Health Systems
CYH
$392M
| $163K | ﹤0.01% |
+54,486
| New | +$229K |
|
546
Geron
GERN
$930M
| $159K | ﹤0.01% |
+44,853
| New | +$179K |
|
547
Perspective Therapeutics
CATX
$336M
| $151K | ﹤0.01% |
+47,386
| New | +$387K |
|
548
Compass Minerals
CMP
$1.25B
| $149K | ﹤0.01% |
+13,253
| New | +$173K |
|
|
AVDX
549
DELISTED
AvidXchange
AVDX
| $144K | ﹤0.01% |
+13,893
| New | +$136K |
|
550
Replimune Group
REPL
$878M
| $140K | ﹤0.01% |
+11,589
| New | +$141K |
|
Similar funds
BIP
BPC
SSA
X
CM
BBVA
IFP
Freestone Grove Partners's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Freestone Grove Partners, which disclosed 569 positions worth $8.16B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Financials and Industrials.
- Freestone Grove Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $8.16B portfolio in Q4 2024.
- Freestone Grove Partners disclosed 569 positions in Q4 2024, its first 13F filing on record.
Based on Freestone Grove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.